Results 121 to 130 of about 2,136 (172)

Venetoclax combined with azacitidine for treatment of a blastic plasmacytoid dendritic cell neoplasm: A case report and literature review. [PDF]

Exp Ther Med
Lai Y, Chen X, Zhou H.
europepmc   +1 more source

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience. [PDF]

Oncotarget
Fei F, Telatar M, Tomasian V, Chang L, Danilova O, Arias-Stella J, Pillai R, Soma L, Tizro P, Becker PS, Stein AS, Marcucci G, Afkhami M.   +12 more
europepmc   +1 more source

Care Optimization for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm Receiving Tagraxofusp. [PDF]

J Adv Pract Oncol
Faysman K, Rubin J, Lubas A, Kujawa T, Hinojosa G, Marx KR, Katsetos J, Galinsky IA.   +7 more
europepmc   +1 more source

Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study. [PDF]

Cancers (Basel)
Solana-Altabella A, Navarro-Vicente I, Rodríguez-Arbolí E, Noriega V, Serrano J, Bernal T, Carrasco-Baraja V, Garcia-Boyero R, Olivier Cornacchia C, Algarra L, López-Briz E, Mena-Durán A, Solano-Tovar J, Botella-Prieto C, Sánchez-Sánchez S, Bergua-Burgues JM, Lloret-Madrid P, Rodenas-Rovira M, Boluda B, Cano-Ferri I, Acuña-Cruz E, Rodríguez-Veiga R, Torres-Miñana L, Centelles-Oria M, Poveda-Andrés JL, Martínez-Cuadrón D, Montesinos P.   +26 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm secondary to acute myeloid leukemia with shared mutations in TET2 and DNMT3A: a case report and literature review. [PDF]

Front Immunol
Sun Y, Liu Y, Liu N, Zhang X, Huang W, Hu L.   +5 more
europepmc   +1 more source

Multi-organ single-cell analysis reveals PLD4 as a biomarker and potential therapeutic target of blastic plasmacytoid dendritic cell neoplasm. [PDF]

Cancer Cell Int
Wang M, Xue X, Wang Z, Wang C, Yu G, Mi Z, Sang X, Wang J, Liu Y, Chen X, Chen S, Zhou G, Liu H, Chen H, Sun Y, Zhang F.   +15 more
europepmc   +1 more source

Clinico-hematopathologic and Genetic Characteristics of Korean Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Single-Center Cohort Study. [PDF]

Ann Lab Med
Kim J, Kim M, Chu D, Cho YU, Hwang SH, Jang S, Seo EJ, Choi EJ, Park HS, Lee JH, Lee JH, Yoon DH, Go H, Park CS, Lee KH, Park CJ, Hwang S.   +16 more
europepmc   +1 more source

Real-world management of blastic plasmacytoid dendritic cell neoplasm at an academic center with a broad regional referral base. [PDF]

Leuk Res Rep
Krah NM, Hoeg R, Shami PJ, Elf SE, Lee LE, Pemmaraju N, Patel AB.   +6 more
europepmc   +1 more source

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Blood Adv
Khalife-Hachem S, Pages A, Akoury E, Bonnet S, Birsen R, Busquet C, Contejean A, Danu A, de Botton S, de Charette M, Dumas PY, Jaccard A, Marfaing-Koka A, Willekens C, Deconinck E, Ghez D.   +15 more
europepmc   +1 more source

Petechiae and a Persistent Violaceous Nodule: A Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm to Dermatology. [PDF]

Case Rep Dermatol Med
Anzelc M, Druskovich C, Cusick A, Franklin M.   +3 more
europepmc   +1 more source